Advertisement

Kawasaki Disease

  • Rakesh Kumar Pilania
  • Surjit Singh
Chapter
Part of the Rare Diseases of the Immune System book series (RDIS)

Abstract

Kawasaki disease (KD) is the commonest cause of acquired heart disease in children in the developed world and is increasingly being reported from developing countries. KD has a predilection for the coronary arteries. Etiology of this disorder is remains an enigma. Diagnosis of KD is essentially clinical with the help of set of clinical criteria. Incomplete KD is said to occur when these criteria are not fulfilled. However, incomplete KD should not be considered as a milder form of the disease. 2D-echocardiography remains the imaging modality of choice for evaluation and monitoring of cardiac complications but often needs to be supplemented by CT coronary angiography. Intravenous immunoglobulin along with aspirin is the gold standard therapy of treatment for KD. However, there is no consensus on treatment of resistant forms of KD. Patients with KD should be on long-term follow-up especially if they have developed coronary artery abnormalities during the acute stage.

Keywords

Kawasaki disease Epidemiology Diagnosis Coronary artery abnormalities Intravenous immunoglobulin 

References

  1. 1.
    Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016;67:1738–49.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21:36–44.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79–85.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Nakamura Y. Kawasaki disease: epidemiology and the lessons from it. Int J Rheum Dis. 2018;21:16–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100:1084–8.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, Kojo T, Aoyama Y, Kotani K, Yanagawa H. Epidemiological observations of Kawasaki disease in Japan, 2013–2014. Pediatr Int. 2018;60:581–7.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Nakamura Y, Yashiro M, Yamashita M, et al. Cumulative incidence of Kawasaki disease in Japan. Pediatr Int. 2018;60:19–22.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, Yu JJ, Choi J-W, Lee K-Y. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012–2014. Pediatr Infect Dis J. 2017;36:482–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Lin M-T, Wu M-H. The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract. 2017;2017:e201720.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen J-J, Ma X-J, Liu F, Yan W-L, Huang M-R, Huang M, Huang G-Y, Shanghai Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J. 2016;35:7–12.PubMedGoogle Scholar
  13. 13.
    Zhang X, Zhang Z, Liu S, Sun J. Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008. Pediatr Cardiol. 2012;33:272–9.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Tang Y, Gao X, Shen J, Sun L, Yan W. Epidemiological and clinical characteristics of Kawasaki disease and factors associated with coronary artery abnormalities in East China: nine years experience. J Trop Pediatr. 2016;62:86–93.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Du Z-D, Zhao D, Du J, Zhang Y-L, Lin Y, Liu C, Zhang T, Beijing Kawasaki Research Group. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J. 2007;26:449–51.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Singh S, Aulakh R, Bhalla AK, Suri D, Manojkumar R, Narula N, Burns JC. Is Kawasaki disease incidence rising in Chandigarh, North India? Arch Dis Child. 2011;96:137–40.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H. Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25:239–45.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Onouchi Y. Genetics of Kawasaki disease: what we know and don’t know. Circ J. 2012;76:1581–6.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Onouchi Y. The genetics of Kawasaki disease. Int J Rheum Dis. 2018;21:26–30.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Dietz SM, van Stijn D, Burgner D, Levin M, Kuipers IM, Hutten BA, Kuijpers TW. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr. 2017;176:995–1009.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Onouchi Y, Fukazawa R, Yamamura K, et al. Variations in ORAI1 gene associated with Kawasaki disease. PLoS One. 2016;11:e0145486.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Shimizu C, Jain S, Davila S, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 2011;4:16–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Rowley AH. Is Kawasaki disease an infectious disorder? Int J Rheum Dis. 2018;21:20–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Orenstein JM, Shulman ST, Fox LM, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012;7:e38998.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Takahashi K, Oharaseki T, Yokouchi Y. Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis. 2018;21:31–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Kao AS, Getis A, Brodine S, Burns JC. Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J. 2008;27:981–5.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis. 2007;20:298–303.PubMedCrossRefGoogle Scholar
  28. 28.
    McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.PubMedCrossRefGoogle Scholar
  29. 29.
    Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K, Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47:232–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Singh S, Agarwal S, Bhattad S, Gupta A, Suri D, Rawat A, Singhal M, Rohit M. Kawasaki disease in infants below 6 months: a clinical conundrum? Int J Rheum Dis. 2016;19:924–8.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Gong GWK, McCrindle BW, Ching JC, Yeung RSM. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr. 2006;148:800–5.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Kumar A, Singh S. BCG site reactivation in Kawasaki disease. Arthritis Rheumatol. 2016;68:2026.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Pilania RK, Bhattarai D, Singh S. Controversies in diagnosis and management of Kawasaki disease. World J Clin Pediatr. 2018;7:27–35.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Chuang G-T, Tsai I-J, Lin M-T, Chang L-Y. Acute kidney injury in patients with Kawasaki disease. Pediatr Res. 2016;80:224.  https://doi.org/10.1038/pr.2016.81.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Singh S, Gupta A, Jindal AK, Gupta A, Suri D, Rawat A, Vaidya PC, Singh M. Pulmonary presentation of Kawasaki disease-a diagnostic challenge. Pediatr Pulmonol. 2017;53:103.  https://doi.org/10.1002/ppul.23885.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Madhusudan S, Singh S, Suri D, Gupta A, Gupta A. Acute anterior uveitis as the presenting feature of Kawasaki disease. Indian J Pediatr. 2014;81:415.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Burgner D, Curtis N. Kawasaki disease as a cause of encephalitis. Arch Dis Child. 2011;96:988–9.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Eladawy M, Dominguez SR, Anderson MS, Glodé MP. Kawasaki disease and the pediatric gastroenterologist: a diagnostic challenge. J Pediatr Gastroenterol Nutr. 2013;56:297–9.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Watanabe T. Pyuria in patients with Kawasaki disease. World J Clin Pediatr. 2015;4:25–9.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017;185:112–116.e1.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Singh S, Bhattad S, Gupta A, Suri D, Rawat A, Rohit M. Mortality in children with Kawasaki disease: 20 years of experience from a tertiary care centre in North India. Clin Exp Rheumatol. 2016;34:S129–33.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250–2.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Altman CA. Clinical assessment of coronary arteries in Kawasaki disease: focus on echocardiographic assessment. Congenit Heart Dis. 2017;12:636–40.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Dahdah N. Not just coronary arteritis, Kawasaki disease is a myocarditis, too. J Am Coll Cardiol. 2010;55:1507; author reply 1507–1508.CrossRefGoogle Scholar
  45. 45.
    Dionne A, Dahdah N. Myocarditis and Kawasaki disease. Int J Rheum Dis. 2018;21:45–9.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Lin Y-J, Cheng M-C, Lo M-H, Chien S-J. Early differentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit. Pediatr Infect Dis J. 2015;34:1163–7.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008;122:e786–90.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Rodo X, Curcoll R, Robinson M, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A. 2014;111:7952–7.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Kushner HI, Macnee RP, Burns JC. Kawasaki disease in India: increasing awareness or increased incidence? Perspect Biol Med. 2009;52:17–29.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Rawat A, Singh S. Biomarkers for diagnosis of Kawasaki disease. Indian Pediatr. 2015;52:473–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Jiang J, Cai Y, Li Z, et al. Screening of differentially expressed genes associated with Kawasaki disease by microarray analysis. Exp Ther Med. 2017;14:3159–64.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Rheumatol Int. 2016;36:551–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Lin K-H, Chang S-S, Yu C-W, Lin S-C, Liu S-C, Chao H-Y, Lee M-TG, Wu J-Y, Lee C-C. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015;5:e006703.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014;78:2521–62.CrossRefGoogle Scholar
  55. 55.
    Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol. 2010;31:242–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Singhal M, Singh S, Gupta P, Sharma A, Khandelwal N, Burns JC. Computed tomography coronary angiography for evaluation of children with Kawasaki disease. Curr Probl Diagn Radiol. 2018;47:238–44.PubMedCrossRefGoogle Scholar
  57. 57.
    Singhal M, Singh S, Gupta P, Khandelwal N, Burns JC. Computed tomography coronary angiography for evaluation of children with Kawasaki disease. Curr Probl Diagn Radiol. 2018;47(4):238–44.PubMedCrossRefGoogle Scholar
  58. 58.
    Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, Nakamura Y, Yashiro M, Belay ED. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015;57:1116–20.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Dallaire F, Fortier-Morissette Z, Blais S, et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease. Pediatrics. 2017;139:e20170098.  https://doi.org/10.1542/peds.2017-0098.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Ho LGY, Curtis N. What dose of aspirin should be used in the initial treatment of Kawasaki disease? Arch Dis Child. 2017;102:1180.1.  https://doi.org/10.1136/archdischild-2017-313538.CrossRefGoogle Scholar
  61. 61.
    McCrindle BW, Cifra B. The role of echocardiography in Kawasaki disease. Int J Rheum Dis. 2018;21:50–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Tremoulet AH. Adjunctive therapies in Kawasaki disease. Int J Rheum Dis. 2017;21:76.  https://doi.org/10.1111/1756-185X.13208.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Singh S, Sharma D, Suri D, Gupta A, Rawat A, Rohit MK. Infliximab is the new kid on the block in Kawasaki disease: a single-centre study over 8 years from North India. Clin Exp Rheumatol. 2016;34:S134–8.PubMedGoogle Scholar
  64. 64.
    Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev. 2018;17:768.  https://doi.org/10.1016/j.autrev.2018.01.024.CrossRefPubMedGoogle Scholar
  65. 65.
    Vijayvergiya R, Bhattad S, Varma S, Singhal M, Gordon J, Singh S. Presentation of missed childhood Kawasaki disease in adults: experience from a tertiary care center in North India. Int J Rheum Dis. 2017;20:1023–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Gordon JB, Burns JC. Management of sequelae of Kawasaki disease in adults. Glob Cardiol Sci Pract. 2017;2017:e201731.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Rakesh Kumar Pilania
    • 1
  • Surjit Singh
    • 1
  1. 1.Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics CentrePost Graduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia

Personalised recommendations